Wednesday, March 6, 2013

• Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Incyte CorporationBusiness Wire (Wed, Mar 6)

Tuesday, March 5, 2013

• Can Myriad Genetics Survive the Supreme Court?at Motley Fool (Tue, Mar 5)

Thursday, February 28, 2013

• The Great Rotation: Fact or fiction?at MarketWatch (Thu, Feb 28)

Wednesday, February 27, 2013

• 2 Value BioPharmacetuicals for Your Portfolioat Motley Fool (Wed, Feb 27)
• Incyte's Jakafi Is Likely A $1 Billion Drugat Seeking Alpha (Wed, Feb 27)

Tuesday, February 26, 2013

• Is Gilead Sciences Destined for Greatness?at Motley Fool (Tue, Feb 26)

Thursday, February 21, 2013

• INCYTE CORP Files SEC form 10-K, Annual ReportEDGAR Online (Thu, Feb 21)

Wednesday, February 20, 2013

• Incyte to Present at Upcoming Investor ConferencesBusiness Wire (Wed, Feb 20)

Monday, February 18, 2013

• U.S. Food and Drug Administration Approved 30% More Drugs in 2012Marketwired (Mon, Feb 18)

Sunday, February 17, 2013

• 5 Stocks Are Center Stage Post Earningsat Wall St. Cheat Sheet (Sun, Feb 17)

Friday, February 15, 2013

• Revenues Rise at IncyteZacks (Fri, Feb 15)

Thursday, February 14, 2013

• Incyte Earnings: Here’s Why Investors are Happy Nowat Wall St. Cheat Sheet (Thu, Feb 14)
• Why Incyte Shares Surgedat Motley Fool (Thu, Feb 14)
• Incyte's CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Thu, Feb 14)
• Incyte Corporation Earnings Call scheduled for 8:30 am ET todayCCBN (Thu, Feb 14)
• INCYTE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Thu, Feb 14)
• Incyte Reports 2012 Fourth-Quarter and Full-Year Financial Results; Provides 2013 Financial Guidance; Updates Shareholders on Key Clinical ProgramsBusiness Wire (Thu, Feb 14)

Tuesday, February 12, 2013

• Novartis Marrow Drug Fails to Win U.K. Agency Backingat Bloomberg (Tue, Feb 12)

Monday, February 11, 2013

• Update on Lilly's TabalumabZacks (Mon, Feb 11)

Tuesday, February 5, 2013

• Incyte Pharmaceuticals Is Primed For A Runat Seeking Alpha (Tue, Feb 5)

Thursday, January 31, 2013

• Lilly Makes the Best of Bad Newsat Motley Fool (Thu, Jan 31)

Wednesday, January 30, 2013

• Foolish Preview: Pfizer Earningsat Motley Fool (Wed, Jan 30)

Thursday, January 24, 2013

• Incyte to Report Fourth Quarter/Year-End 2012 Financial Results on February 14Business Wire (Thu, Jan 24)

Sunday, January 20, 2013

• Heroic, But Profitable For Investors?at Motley Fool (Sun, Jan 20)

Friday, January 18, 2013

• 4 Promising Growth Stories In Therapeuticsat Seeking Alpha (Fri, Jan 18)

Add INCY News to My Yahoo!